Euro Funding for Uscom Pulmonary Research
Filed with ASX · · 3 pages · English
SYDNEY, Australia, Tuesday 11 July 2017: Uscom Limited (ASX code: UCM) (the Company or Uscom) announced the award of an additional European scientific research grant to Uscom Europe to fund research and development of new digital pulmonary disease management technologies. This second stage of the grant, for a further AU $330k, takes the Uscom Europe grant total for this project to AU $0.82M over t
Earlier from Uscom
- Uscom SpiroSonic Devices for Spanish Health Project
- Uscom SpiroSonic Devices for French Lung Transplant Study
- Uscom boosts global sales and marketing
- Uscom Achieves First Cash Flow Positive Quarter Appendix 4C
- Uscom Achieves First Cash Flow Positive Quarter
Later from Uscom
- TGA for Uscom SpiroSonic Digital Spirometers
- Uscom BPplus Distributor for SE Asia
- New USCOM 1A digital connectivity feature released
- USCOM cost effective replacement for ICU Ultrasound
- BP Plus and Mount Everest Hypertension Study
Follow Uscom into a list and get an email when it puts out news.
Follow Uscom